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Abstract
Objective: This article reviews the literature on biomaterials used for bone regeneration. 
Material and method: A total of seventeen bibliographic sources were found using the MEDLINE database and to 
avoid the variability of the search terms the thesaurus Mesh was used.
Results: These materials act essentially due to their osteoconductive ability, although their osteoinductive capacity 
is being improved with the use of growth factors. As to their effectiveness, many differences exist between them 
and some even affect bone regeneration negatively.
Conclusions: Biomaterials used for bone regeneration are valid when the correct material is used. As yet the os-
teogenic capacity of autogenous bone has not been equalled by biomaterials. Tissue engineering has caused great 
interest because of its many possibilities, although more studies are necessary in order to achieve the ambitious 
expectations when it comes to tissue or organ regeneration in the human body.
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Introduction
The life expectancy of the current population has in-
creased considerably over recent decades due to im-
provements in the quality of life of individuals. One of 
the consequences of this phenomenon has been the in-
crease in injuries and bone disease in older people who 
have a diminished bone regeneration capacity. Defects 
in oral and craniofacial tissues, resulting from trauma, 
tumours, infections, abnormal skeletal development or 
progressive deforming diseases, present a formidable 
challenge and restoration of these tissues is a subject of 
clinical, basic science and engineering concern (1,2).
Bone is a highly vascularized and innervated connec-
tive tissue. It is composed of cells and mineralized or-
ganic matrix. Bone is the only body tissue capable of 
regeneration and remodelling process (it is in constant 
formation and resorption, this allows the renovation of 
5-15% of the total bone mass per year under normal con-
ditions). It is regulated by genetic, mechanical, vascular, 
hormonal, nutritional, and local factors. Amongst local 
factors, growth factors and cytokines, and recently the 
bone matrix proteins have been implicated as modu-
lators of other local factors. Growth factors (GFs) are 
polypeptides produced by the bone cells themselves or 
in extra-osseous tissue, and act as modulators of the cel-
lular functions, fundamentally growth, differentiation, 
and proliferation. The main GFs acting on the skeleton 
are IGF-I and II (insulin-like growth factor I and II), 
Transforming Growth Factor-β (TGF-β), Bone Mor-
phogenetic Proteins (BMP), Platelet-Derived Growth 
Factor (PDGF), Fibroblastic Growth Factor (FGF) and 
Vascular Endothelial Growth Factor (VEGF) (3-5).
Autografts have primarily been the material of choice to 
replace lost bone, although the use of autografts comes 
with some disadvantages such as the limited quantity 
available and its use also requires additional surgical 
procedures, and therefore, longer surgical time and pos-
sible complications of the wound of the donor site such 
as bleeding, pain and infection among others (1,2, 6-8). 
Allografts and xenografts have the potential of transfer-
ring pathogens (2,9). To avoid the biological risk, these 
materials are subjected to exhaustive procedures which 
have dramatic effects primarily on their osteogenic and 
osteoinductive properties and these procedures can also 
reduce their structural integrity leading to graft frac-
ture (2,6,8). In order to minimize these complications, 
the alloplastic graft (synthetic bone graft substitute) has 
been developed. Synthetic bone graft possess both oste-
ointegrative and osteoconductive properties (6,10). The 
benefits of synthetic grafts include their availability, 
sterility and reduced morbidity (6). Long-term compli-
cations include stress shielding, loosening and mechan-
ical or chemical breakdown of the material itself and 
they furthermore, lack the ability to adapt functionally 
(2). Synthetic grafts can be classified according to their 
chemical composition into four major categories: metal-
lic implants such as titanium and stainless steel; ceram-
ics such as calcium phosphate, alumina and glass; poly-
mers such as polymethylmethacrylate and polyurethane 
and the fourth group is made up of composites , which 
are obtained after mixing several of the above (1).
The desire to create more biological alternatives has 
inspired the development of growth factors and tissue 
engineering (1,2). The three main design components 
in tissue engineering are cell for osteogenesis, their ex-
tracellular matrix (scaffolds) for osteoconduction and a 
signalling system for osteoinduction, which can be used 
individually or in combination (2,8).
Biomaterials were first developed in the 1960 s´ and 
1970 s´. Currently the third generation of these materi-
als is being developed so as to achieve bioactive and 
resorbable materials, capable of stimulating a specific 
cellular response at a molecular level (11).
Material and Methods
A search of published articles was carried out using doc-
umental or artificial language so that the words had no 
variability, so it was essential the choice of appropriate 
descriptors representative of the theme we were studying. 
We searched in the MEDLINE database produced by the 
National Library of Medicine in the United States. For 
this, one acceded by means of Internet to the link www.
pubmed.gov. We used the Mesh thesaurus to introduce 
descriptors. We conducted a total of five bibliographic 
searches and a total of seventeen bibliographic sources 
were found. When we introduced “bone” in the Mesh we 
obtained numerous items. We selected Bone Regenera-
tion y Bone Transplantation. We searched in PubMed for 
Bone Transplantation using the following inclusion cri-
teria: articles published after July 2007, studies in adults 
between the ages of 19 and 44 and the articles had to be 
published in English or Spanish. Out of 559 articles 2 
were selected (9,12). Over 12,000 articles were found for 
Bone Regeneration. We carried out two types of bibli-
ography searches. The first had the following inclusion 
criteria: full free text had to be available so as to obtain 
information immediately, they had to be published after 
July 2004 and in English or Spanish. Out of 244 articles 
8 articles were selected (3,4,7,10, 13-16). In the second 
search, we looked for articles published after July 2008 
so as to find the most recent information and these ar-
ticles also had to be in English or Spanish. Out of 579 
obtained 3 were selected (5,8,17).
Oral Tissue Engineering was searched for in PubMed 
with the following inclusion criteria: articles published 
after July 2008 and again in English or Spanish. We ob-
tained 190 articles of which only one was selected (2).
Finally 3 of the reviewed articles, published after April 
2001 and in English, were bibliographic references sug-
gested by other dental surgeons (1,6,11).
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Results
Of the articles selected in this review, we determined 
how many were purely theoretical and how many were 
both theoretical and practical, as shown in (Fig. 1), of 
the eight theoretical-practical articles two are in vitro, 
three in animals and three in humans. 
In addition, articles were classified according to topic of 
study. The percentages are shown in (Fig. 2). The most 
numerous group compares different biomaterials and 
the smallest group contains tissue engineering articles. 
An important property which biomaterials must have 
so as to achieve optimal regeneration is their rate of 
degradation which should be similar to the rate of bone 
formation, that is to say, the mass of biomaterial must 
allow bone formation inside and persist until total bone 
replacement is achieved (2,7). Another interesting fac-
tor about the design of these materials is that the mass 
is typically maximized by maximizing porosity, where 
as mechanical properties are frequently maximized by 
minimizing porosity. One of the articles focuses on as-
sessing the effect of the pore size of calcium phosphate 
scaffolds. Four pore sizes (150, 260, 510, 1220 µm) were 
used and they were evaluated at six, twelve and twenty-
four weeks. The study showed that all the pore sizes 
Fig. 2. Topic of study.
Fig. 1. Type of study.
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were biocompatible, osteoconductive and formed bone 
(2,13).
Calcium phosphate appears to have osteoinductive 
qualities by ionic interaction with the environment sur-
rounding it (1). Table 1 was prepared to demonstrate the 
most important characteristics of synthetic bone grafts 
and the great diversity of results obtained (6,10,14).
In one of the articles reviewed, biomaterials were used 
to increase the alveolar ridge. The results varied depend-
ing on the biomaterial used, one of them even delayed 
the natural process of bone regeneration (7).
The application of biomaterials can be successful in 
the use of immediate implants. In one study a bioactive 
glass (PerioGlas ®) was joined with autogenous bone 
and blood of the patient. They found that this combina-
tion is suitable for use in fresh sockets around immedi-
ate implants. The success rate was 100% after twenty-
four months of follow-up (15). In another study in which 
the surface of the implant was treated with bioceramics 
or ions, the rate of osteointegration was improved (17).
When performing maxillary sinus lifts the use of bioma-
terials can also be useful. This is demonstrated in one 
of the articles reviewed where a mixture of autogenous 
bone and β-tricalcium phosphate was prepared. The si-
nus lift and implant placement were performed during the 
same surgical procedure. After an interval of twenty-seven 
to fifty-three months, no cases of implant failure were ob-
served (12). Another material often used in these cases is a 
bovine hydroxyapatite, for example, Bio-Oss (14).
In another article biomaterials were successfully used 
for repairing surgically maxillary cystic bone defects. 
A bioactive glass reinforced with hydroxyapatite regis-
tered as Bonelike was used. All patients showed good 
bone regeneration after forty-eight weeks (9).
When considering tissue engineering, an ideal bone 
substitute should possess the following design require-
ments: a) biocompatibility, b) conductivity for attach-
ment and proliferation of committed cells or heir pro-
genitors and production of new extracellular matrix, 
c) ability to incorporate inductive factors to direct and 
enhance new tissue growth, d) support of vascular in-
growth for oxygen transport, e) mechanical integrity to 
support loads at the implant site, f) controlled, predicta-
ble, reproducible rate of degradation into non-toxic spe-
cies that are easily metabolized or excreted and g) easy 
and cost-effective processing into irregular 3D shapes 
of sufficient size to fill clinically relevant defects (2).
GFs bind to target cell receptors and induce an intracel-
lular signal transduction that reaches the nucleus and 
determines the biological response (5).
Bone Morphogenetic Proteins (BMPs) is the generic 
name of a family of proteins able to achieve the trans-
formation of connective tissue into bone tissue, for 
which they are considered osteoinductive, therefore, 
are capable of inducing bone formation at ectopic sites. 
Likewise, they are able to stimulate the differentiation 
of the stem cells towards different cell lines (adipose 
tissue, cartilage and bone). BMPs are not only present 
in the bone matrix, but can also be synthesized by cells 
of other lineages (e.g., macrophages). To date, 20 types 
and subtypes of BMPs have been reported. All BMPs 
belong to the TGF-β superfamily except BMP-1. They 
are currently considered to be the most powerful factors 
in osteoblastic differentiation (4,17).
Platelet-rich plasma (PRP) was proposed for use in 
oral and maxillofacial surgery, due to its high content 
of GFs. PRP can enhance regeneration mediated by the 
releasing of GFs, such as TGF-β, PDGF, and IGF-1, that 
are present inside of the α- granules of platelets (17).
Current sources for delivery of a GF mixture into the 
site of bone repair are platelet gel and demineralised 
bone matrix (17).
Discussion
It is interesting how Mah J et al. (10) and Schmitt SC 
et al. (16) when comparing different alloplastic bone 
grafts find great variability in their results .The studies 
differ in that the first was an in vivo study using rats, 
whilst the latter is carried out in vitro with similar cells 
to ovine osteoblast-like cells. The first study showed 
that with regards to the formation of new bone in total 
defect, there were no significant differences with the 
control group, but there were significant differences 
when particles of biomaterial in direct contact with the 
new formed bone were included (Table 1). If we look at 
the data from the second study, the sample where the 
largest growth occurred was in the cell culture without 
any biomaterial.
Other authors prefer to select a biomaterial and study it 
in a specific situation. This is the case for the study car-
ried out by Masago H et al., who used PRP along with 
β-tricalcium phosphate granules, calcium phosphate ce-
ment powder and web form of titanium fibers (7).
Although many biomaterials have had a lengthy his-
tory of clinical success, very few interact with their 
surrounding host environment or promote integration 
with host tissue in an intelligent, proactive fashion. The 
desire for more biological approaches to biomaterial de-
sign that could yield materials that are more instructive 
to cells has led to an expansion and paradigm shift in 
the field of biomaterials. This is why GF, BMP, PRP and 
tissue engineering are the topic of study of many scien-
tific investigations at this moment in time. These lines 
of investigation are based on the latest findings about 
biomaterials for bone regeneration. We found that the 
most recent articles were the ones that most considered 
these topics: Scheller EL et al., Devescovi V et al., Tor-
roni A, and Avila G et al. (2,5,8,17).
Some authors found that the association of biomaterials 
with autograft is beneficial for bone regeneration. This 
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was the case for Aguirre Zorzano LA et al. (12), who as-
sociated autogenous bone with β-tricalcium phosphate. 
Gatti AM et al. (15) combined bioactive glass with the 
autogenous bone. Others prefer to associate different bio-
materials as can be seen in a study carried out by Sousa 
RC et al., who used a composite (Bonelike®) with a glass 
and  hydroxyapatite base (9). Another line of investiga-
tion carried out by Avila G et al. was to apply 4 differ-
ent substances to the implant surface (ceramics, bioac-
tive proteins, ions and polymers) so as to improve bone 
regeneration (17). Scheller EL et al., Devescovi V et al. 
and Torroni A consider the biological mediators play an 
important role in improving bone regeneration (2,5,8).
There is still much work needed and many questions to 
be resolved such as the way the biomaterial is applied 
(e.g. gel, foam or fibre), identification of appropriate cell 
sources for a desired application (e.g. autogenous ver-
sus allogenic cells; primary cells, cell lines, genetically 
modified cells versus stem cells; adult versus embryon-
ic cells) o identification of spatial and temporal signals 
(e.g. growth factors, cytokines, chemokines) for tissue-
specific differentiation and morphogenesis and the ap-
proach to deliver these signals (soluble versus insoluble; 
temporal and spatial control) represent design choices 
along the third axis of the tissue engineering triad (2).
When the size of the lesion is larger than 6 to 9 cm, 
the use of an autograft is not efficient and so the need 
for tissue engineering intensifies. Tissue engineering 
also comes with some drawbacks. The production of 
recombinant growth factors, collection and transport of 
the biopsies and culture of autologous cells are some 
of the factors that make tissue engineering time-, mon-
ey- and labour-consuming. Another problem is that an 
engineered bone graft involves the inadequate vascu-
larization of the inner portion of graft. This limits the 
formation of bone at the centre of the smaller grafts, and 
represents an insurmountable obstacle in the creation 
of larger grafts. The solution is to induce angiogenesis 
within the construct. Further improvement of biomate-
rials is needed in order to make tissue engineering more 
successful and, ideally, even unnecessary (1,8).
Many variables have to be considered so as to achieve 
the best results in each individual clinical situation. For 
this a profound knowledge of biomaterials and their se-
lection criteria is necessary as there are multiple pos-
sibilities available.
Conclusions
Currently, biomaterials are still far from ideal bone 
substitutes. They have certain disadvantages compared 
with autografts, because they lack the osteogenic and 
osteoinductive properties, but they have significant ben-
efits in terms of availability, avoiding the risk of donor 
site complications and, of course, their well-developed 
osteointegrative and osteoconductive properties.
The studies seek to improve the characteristics of these 
bone substitutes. The two most important lines of re-
search are based on one hand, on composites (combina-
tion of several biomaterials), and on the other hand, tis-
sue engineering and growth factors. The latter emerges 
as an innovative, sophisticated and interesting field, be-
cause it is the nearest approximation to the autogenous 
graft, the only osteogenic material. Significant progress 
is expected in this young scientific field of biomaterials 
so as to achieve the needs of society and move towards 
a future of greater success.
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